Recent Advancement and Patents of the Lipid Polymer Hybrid Nanoparticles

In recent years, robustness and surface engineering of dosage form made improvement in pharmacokinetics with decrease in dose of drug. Specifi city with adherence of ligands has now become the reality as surface modifi cation can easily deceive phagocytic system

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-12-31

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.17352/OJC.000005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery.

  2016cited by this paper
• Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.

  2016influential reference
• Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.

  2016cited by this paper
• Influence of cationic lipid concentration on properties of lipid–polymer hybrid nanospheres for gene delivery

  2015cited by this paper
• Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery

  2014cited by this paper
• Efficient pH Dependent Drug Delivery to Target Cancer Cells by Gold Nanoparticles Capped with Carboxymethyl Chitosan

  2014cited by this paper
• A multilayered supramolecular self-assembled structure from soybean oil by in situ polymerization and its applications.

  2013cited by this paper
• Surface Engineering of Liposomes for Stealth Behavior

  2013cited by this paper
• Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.

  2013cited by this paper
• Polysaccharide-Based Micelles for Drug Delivery

  2013cited by this paper
• Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.

  2012cited by this paper
• Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies

  2012cited by this paper
• Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review

  2012influential reference
• Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices.

  2012cited by this paper
• Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery

  2011cited by this paper
• The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.

  2011cited by this paper
• Targeted drug delivery to tumors: myths, reality and possibility.

  2011cited by this paper
• Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.

  2011cited by this paper
• LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS

  2010cited by this paper
• The origins and evolution of "controlled" drug delivery systems.

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.

  2008cited by this paper
• Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.

  2007cited by this paper
• Nanoparticles with lipid core and polymer shell structures for protein drug delivery prepared by nanoencapsulation

  2006cited by this paper
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• Argonaute—a database for gene regulation by mammalian microRNAs

  2005cited by this paper
• Recent Advances in Tumor-Targeting Anticancer Drug Conjugates

  2005cited by this paper
• Self-assembled polymeric nanoparticles of poly(ethylene glycol) grafted pullulan acetate as a novel drug carrier

  2004cited by this paper
• Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties

  2003cited by this paper
• Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.

  2003cited by this paper
• Causes and effects of heterogeneous perfusion in tumors.

  1999cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Causes and Effects.

  1957cited by this paper
• Adipose tissue and lipid metabolism

  year unknowncited by this paper

• Polymer encapsulation of ruthenium complexes for biological and medicinal applications

  2019cites this paper